InvestorsHub Logo
Followers 285
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: dr_lowenstein post# 29020

Friday, 09/28/2012 5:39:19 PM

Friday, September 28, 2012 5:39:19 PM

Post# of 402078
Huh No Pfizer or Purdue mentioned! LOL LOL YEP TIC TOC IS EXACTLY RIGHT!
LOOK BELOW....


http://formularyjournal.modernmedicine.com/formulary/data/articlestandard/formulary/382012/789672/article.pdf

"ELI-216/oxycodone/naltrexone

Elite Pharmaceuticals

an oral, long-acting opioid receptor antagonist (abuseresistant
opioid combination)/for the treatment of pain
phase 3"

One has to wonder why Drug Watch's Dr. Kaufman, did not include any of the Pfizer and Purdue ongoing clinical studies in her listed "heads-up on pharmaceuticals in late-stage development"

Dr. Kaufman has highly acclaimed credentials with extensive experience in Pharmaceuticals and would know of all the ongoing phase 3 trials from which she compiled her Sept 2012 list.

http://primeinc.org/faculty/biography/362/Michele_B_Kaufman,_PharmD,_B_Pharm,_RPh
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News